Summary
Researchers are looking for new ways to treat ovarian cancer (OC). Current treatment for
OC may start with surgery to remove as much of the cancer as possible. After surgery,
people may receive chemotherapy. After chemotherapy, standard care options may include:
- Maintenance treatment, which is used after another therapy to keep the cancer from
growing, spreading, or coming back. Bevacizumab is a targeted therapy used as
standard maintenance treatment. Targeted therapy works to control how specific types
of cancer cells grow and spread.
- Observation, which is watching to see if cancer grows or worsens
The study medicine, sacituzumab tirumotecan (also called sac-TMT), is a targeted therapy.
The goal of this study is to learn if people who receive sac-TMT maintenance treatment
with or without bevacizumab live longer without the cancer getting worse than people who
receive standard care.